+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

From
Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Metastatic Colorectal Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Metastatic Colorectal Cancer - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 154 Pages
  • Global
From
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Familial Adenomatous Polyposis - Epidemiology forecast- 2032 - Product Thumbnail Image

Familial Adenomatous Polyposis - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
Anal Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anal Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Colorectal Cancer (CRC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Colorectal Cancer (CRC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anus Neoplasms - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anus Neoplasms - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Colorectal Neoplasm - Epidemiology Forecast to 2032 - Product Thumbnail Image

Colorectal Neoplasm - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
Colorectal Cancer KOL Interview - UK - Product Thumbnail Image

Colorectal Cancer KOL Interview - UK

  • Newsletter
  • May 2024
  • 14 Pages
  • United Kingdom
Loading Indicator

The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells. Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more